Cargando…
An historical overview over Pharmacovigilance
Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the qua...
Autores principales: | Fornasier, Giulia, Francescon, Sara, Leone, Roberto, Baldo, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132952/ https://www.ncbi.nlm.nih.gov/pubmed/29948743 http://dx.doi.org/10.1007/s11096-018-0657-1 |
Ejemplares similares
-
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018) -
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
por: Francescon, Sara, et al.
Publicado: (2018) -
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
por: Francescon, Sara, et al.
Publicado: (2016) -
Pharmacovigilance in oncology
por: Baldo, Paolo, et al.
Publicado: (2018) -
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
por: Fornasier, G., et al.
Publicado: (2018)